A Wolf Greenfield Podcast IP Talk

2025 promises to be another busy year for intellectual property law. In this episode of IP Talk with Wolf Greenfield, you’ll hear Wolf Greenfield attorneys from a variety of practice areas reviewing some of the top issue...

Phil Hamzik is an Associate in Wolf Greenfield’s Pharmaceutical Practice. From protecting key platform technologies to advising on drug product life cycle management, Phil works closely with pharmaceutical and biotechnol...

Ryan MacDougall is the Chief Business Development Officer for Wolf Greenfield. Since joining the firm in 2010, he has worked closely with the firm's executive leadership, management, and practice groups to build and impl...

Dan Rudoy is a shareholder and executive committee member at Wolf Greenfield. As part of the Electrical & Computer Technologies Practice, Dan works closely with clients developing technology in a wide variety of area...

Tonia Sayour is a patent, trademark, and copyright attorney in Wolf Greenfield’s New York office. She has nearly two decades of experience counseling clients in all areas of intellectual property law. Tonia also frequent...

The Wolf Greenfield Summer Program gives aspiring attorneys a firsthand look at life inside of a thriving law firm. Participants are assigned to a specific Wolf Greenfield practice group, but they are also exposed to mul...

Artificial intelligence has extraordinary potential, but it also presents a number of daunting challenges. One is the high energy consumption of the computer chips required to drive the programs. Lightmatter is developin...

Meaghan Luster focuses her practice at Wolf Greenfield on patent litigation. Meaghan’s experience includes conducting pre-suit diligence, fact and expert discovery, claim construction, and motion practice in US district ...

John Harmon is a shareholder in both the Mechanical and Chemical & Materials Technologies Practices at Wolf Greenfield. He represents clients in industry and academia in a wide range of technologies related to the me...

Rob Sahr is a shareholder in Wolf Greenfield’s Biotechnology Practice. He develops strategies for life science companies to maximize exclusivity for therapeutic and diagnostic products. Rob has also assisted federal gran...